Vireo Growth Inc. Announces Third Quarter 2026 Results

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Vireo Growth Inc. Announces Third Quarter 2026 Results Q3 GAAP revenue of $253.7 million increased 177% year-over-year, driven by recently closed M&A transactions. Q3 proforma revenue of $277.0 million, gives effect to the acquisitions of C21 Investments, certain Pha

Original reporting
Published Nov 10, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 12:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$VREOF
Bullish
high confidence
Mentioned
$VREOF
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$VREOFBullishLow
01

Why it matters

The earnings beat and acquisition announcements provide fresh material for traders evaluating the cannabis sector.

02

Market read

First‑report earnings and M&A news for Vireo Growth, a micro‑cap cannabis firm, offering new data for short‑term positioning.

03

What to watch

High debt load ($293M) and reliance on financing may limit upside despite growth.

Relevance 7/10Novelty 6/10Timing: today

Background

SEC Form 8‑K filing discloses Vireo Growth's Q3 2026 financials and recent acquisition activity.

Company-level read

Ticker impact

$VREOFBullishHigh confidence
Context

Vireo Growth reported Q3 2026 results with 177% YoY revenue growth and multiple acquisitions, expanding to ~270 dispensaries.

Expected impact

likely upside as market prices in the revenue surge and expansion news

Evidence & confidence

Revenue jumped to $253.7M and the company closed several acquisitions, indicating scale and future earnings potential.

Market effects

Highlights consolidation trend in the cannabis sector, may spur further M&A activity.

Expands Vireo's footprint across 15 U.S. states, potentially boosting regional cannabis supply.

Limited to U.S. cannabis market; minimal broader market effect.

Counterpoint

Rapid expansion could strain cash flow and integration risk, possibly weighing on the stock.

Key entities

  • Vireo Growth Inc.

    Vertically integrated cannabis operator reporting Q3 results.

Related articles

$VREOFMed

Vireo Growth Inc. Announces Third Quarter 2026 Results

Vireo Growth Inc. reported Q3 2026 revenue of $253.7M, up 177% YoY, driven by acquisitions. Proforma revenue was $277M. The company closed Q3 with $106.8M in cash and expects to remain acquisitive. Key acquisitions include C21 Investments and PharmaCann Colorado assets. Vireo launched a share repurchase program and expanded financing capacity.

$VREOFMed

Vireo Growth Inc. (VREOF): Completion of Acquisition or Disposition of Assets

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Vireo Growth Inc. Completes Acquisition of C21 Investments Inc. 08/21/2026 Transaction expands Vireo’s Nevada footprint with three leading dispensaries in Nevada and approximately 104,000 sq. ft. of cultivation and production capacity MINNEAPOLIS and VANCOUVER, Briti

$VREOFLow

Vireo Growth Inc. (VREOF): Completion of Acquisition or Disposition of Assets

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Vireo Growth Announces Asset Based Credit Facility Facility enhances financial flexibility and supports continued execution of the Company's disciplined growth strategy MINNEAPOLIS, Minnesota, August 7, 2026 -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or

$VREOFMed

Vireo Growth Inc. Announces Second Quarter 2026 Results

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Vireo Growth Inc. Announces Second Quarter 2026 Results Q2 GAAP revenue of $209.3 million increased 335% year-over-year, driven by recently closed M&A transactions. Q2 proforma revenue of $254.9 million, gives effect to the acquisitions of Hawthorne, Bridgewell, and